RAY1225 for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Feb 2024: Trial registered, NCT06254261
  2. 21 Feb 2024: Trial started, NCT06254261

The trials

NCT06254261: A Study of RAY1225 in Participants With Obesity

State
Under way
Phase
Phase 2
People
270 planned
Started
21 Feb 2024
Primary completion
20 Dec 2025
Arms
RAY1225 (cohort 1), RAY1225 (cohort 2)
Results
None posted
  1. 12 Feb 2024: Trial registered
  2. 21 Feb 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.